Allodynia: Causes, Symptoms, How Long Does It Last?

Allodynia is the occurrence of pain sensations in response to stimuli that normally do not cause pain. It is noted in causalgia, neuropathies and polyneuropathies, herpes zoster, multiple sclerosis, migraine, conditions after spinal cord injuries, strokes, and spinal surgeries.

To determine the cause of allodynia, data from interviews, general and neurological examinations, electrophysiological, neuroimaging, and laboratory tests are used.

Treatment includes analgesics, blocks with anesthetics, vitamins, antidepressants, physiotherapeutic methods. Sometimes operations are recommended.

Types of Allodynia

Allodynia is not a uniform condition—it manifests in various forms depending on the type of stimulus that triggers the pain. Each type of allodynia corresponds to specific sensory pathways and underlying mechanisms. Below, we explore the four primary types of allodynia: cold, hot, mechanical, and dynamic, detailing their characteristics, causes, and clinical significance.

1. Cold Allodynia

Cold allodynia occurs when exposure to cold temperatures—even mild ones—triggers an abnormal pain response. This type of allodynia is particularly common in individuals with nerve damage or certain neurological conditions.

Characteristics:

• Pain or discomfort in response to cold air, cool water, or touching cold objects.
• Sensations may range from a sharp, stabbing pain to a dull ache or burning feeling.
• Often localized to areas with nerve damage, such as the hands, feet, or face.

Common Causes:

• Chemotherapy-Induced Peripheral Neuropathy (CIPN): Certain chemotherapy drugs, such as oxaliplatin, can damage peripheral nerves, leading to heightened sensitivity to cold.
• Trigeminal Neuralgia: Cold stimuli, such as a breeze or cold water on the face, can trigger excruciating pain in individuals with this condition.
• Diabetic Neuropathy: Poorly controlled diabetes can result in nerve damage, making extremities particularly sensitive to cold.
• Postherpetic Neuralgia: Following a shingles outbreak, cold sensitivity may persist in the affected dermatome.

Cold allodynia can significantly impact daily life, particularly in colder climates. Patients may avoid cold environments or develop anxiety related to cold exposure. Management often involves avoiding cold triggers and using medications that modulate nerve activity, such as gabapentin or pregabalin.

2. Hot Allodynia

Hot allodynia is characterized by pain or discomfort in response to heat or warm stimuli. This type is less common than cold allodynia but can be equally debilitating.

Characteristics:

• Pain triggered by warm water, hot beverages, or exposure to warm environments.
• Sensations may include burning, stinging, or throbbing pain.
• Often affects areas with compromised nerve function or inflammation.

Common Causes:

• Small Fiber Neuropathy: Damage to small, unmyelinated nerve fibers can lead to abnormal heat sensitivity.
• Complex Regional Pain Syndrome (CRPS): In CRPS, the affected limb may become hypersensitive to both cold and heat due to dysfunctional pain signaling.
• Erythromelalgia: A rare condition characterized by burning pain, redness, and warmth in the extremities, often triggered by heat exposure.
• Sunburn or Radiation Therapy: Severe sunburn or radiation-induced skin damage can temporarily heighten heat sensitivity.

Hot allodynia can limit a patient’s ability to tolerate warm environments or engage in activities like bathing or cooking. Treatment may include topical analgesics, nerve blocks, or medications that reduce nerve hyperexcitability.

3. Mechanical Allodynia

Mechanical allodynia, also known as static mechanical allodynia, occurs when light touch or pressure—such as the brush of clothing or a gentle pat—elicits pain. This is one of the most common and disruptive forms of allodynia.

Characteristics:

• Pain triggered by non-painful mechanical stimuli, such as:
  • Light stroking of the skin.
  • Pressure from clothing, bedsheets, or jewelry.
  • Gentle palpation during a physical exam.
• Sensations may feel like sharp stabbing, burning, or deep aching.

Common Causes:

• Fibromyalgia: Mechanical allodynia is a hallmark of fibromyalgia, where widespread pain is exacerbated by even minimal touch.
• Post-Surgical or Post-Traumatic Neuropathy: Scars or injured areas may become hypersensitive to touch during healing.
• Migraine: Many migraine sufferers experience cutaneous allodynia, where even combing their hair or resting their head on a pillow can provoke pain.
• Peripheral Neuropathy: Conditions like diabetic neuropathy or HIV-associated neuropathy can cause mechanical hypersensitivity in the hands and feet.

Mechanical allodynia can severely impair quality of life, making routine activities like dressing or hugging painful. Treatment strategies often include:

• Topical anesthetics (e.g., lidocaine patches).
• Oral medications (e.g., antidepressants, anticonvulsants).
• Physical therapy to desensitize affected areas.

4. Dynamic Mechanical Allodynia

Dynamic mechanical allodynia is a subtype of mechanical allodynia where pain is triggered specifically by moving or brushing stimuli, such as a light stroke or rubbing motion across the skin.

Characteristics:

• Pain provoked by dynamic (moving) touch rather than static pressure.
• Examples include:
  • Rubbing a towel against the skin.
  • The motion of a bedsheet sliding over the legs.
  • Lightly running a finger across the arm.
• Sensations are often described as burning, stinging, or electric shock-like.

Common Causes:

• Neuropathic Pain Syndromes: Conditions like postherpetic neuralgia or CRPS often feature dynamic mechanical allodynia.
• Spinal Cord Injury: Damage to the spinal cord can disrupt inhibitory pain pathways, leading to heightened sensitivity to moving stimuli.
• Trigeminal Neuralgia: Dynamic stimuli, such as wind blowing on the face, can trigger severe pain attacks.
• Chemotherapy-Induced Neuropathy: Patients undergoing chemotherapy may develop dynamic allodynia in their hands and feet.

Dynamic mechanical allodynia can be particularly challenging because it is triggered by movements that are difficult to avoid. Management may involve:

• Desensitization therapy (gradual exposure to moving stimuli).
• Medications that target nerve hyperexcitability (e.g., gabapentinoids).
• Lifestyle adjustments, such as wearing loose, soft clothing to minimize friction.

Comparison of Allodynia Types

Pathophysiological mechanisms of Allodynia

Allodynia results from complex alterations in pain processing pathways occurring at multiple levels of the nervous system. Understanding these mechanisms helps explain why non-painful stimuli can trigger pain sensations and guides the development of targeted therapeutic approaches.

Peripheral sensitization

In peripheral sensitization, damaged or inflamed peripheral nerves become hyperexcitable due to:

• Ion Channel Alterations: Injury to peripheral neurons leads to upregulation and redistribution of voltage-gated sodium channels (particularly Nav1.7, Nav1.8, and Nav1.9), resulting in decreased activation thresholds and increased membrane excitability. This causes neurons to fire in response to normally subthreshold stimuli.
• Inflammatory Mediator Effects: Following tissue damage, inflammatory mediators including prostaglandins, bradykinin, serotonin, and various cytokines (IL-1β, IL-6, TNF-α) bind to receptors on nociceptors, triggering intracellular signaling cascades that phosphorylate receptor proteins and ion channels, lowering their activation thresholds.
• Phenotypic Switching: Low-threshold Aβ mechanoreceptors, which normally respond to light touch and vibration, begin expressing neuropeptides typically found in nociceptive C-fibers. This causes mechanoreceptors to function more like pain fibers, contributing to touch-evoked pain.
• Sprouting of Nerve Fibers: Following nerve injury, aberrant sprouting and reorganization of nerve fibers can create inappropriate connections between tactile and pain pathways.

Central sensitization

Central sensitization involves neuroplastic changes in the central nervous system, particularly at the spinal cord and brain level:

• Wind-up Phenomenon: Repeated activation of C-fibers leads to progressively increasing responses in dorsal horn neurons due to temporal summation of slow synaptic potentials, primarily mediated by NMDA receptors.
• Glutamate Receptor Modulation: Persistent nociceptive input causes upregulation and enhanced phosphorylation of NMDA and AMPA receptors, increasing neuronal excitability in pain processing pathways.
• Loss of Inhibitory Control: Reduced activity of inhibitory interneurons containing GABA and glycine in the dorsal horn removes the natural “brakes” on pain transmission. This disinhibition can result from death of inhibitory interneurons or reduced effectiveness of descending pain modulatory pathways.
• Glial Cell Activation: Microglia and astrocytes become activated following nerve injury and release pro-inflammatory cytokines, chemokines, and growth factors that enhance neuronal excitability and contribute to central sensitization.
• Synaptic Remodeling: Long-term potentiation (LTP) at synapses in pain pathways strengthens connections between neurons, similar to memory formation. This creates a “pain memory” that can persist even after the original injury has healed.

Neuronal circuit reorganization

In chronic conditions leading to allodynia, substantial reorganization occurs in sensory processing circuits:

• Spinal Cord Reorganization: Low-threshold Aβ fibers that normally terminate in deeper laminae of the dorsal horn sprout into superficial laminae (I-II) where nociceptive information is processed. This anatomical reorganization allows touch information to directly access pain-processing circuits.
• Cortical Reorganization: Chronic pain conditions cause functional and structural changes in somatosensory cortex, thalamus, and limbic structures, altering the brain’s interpretation of sensory stimuli.
• Altered Descending Modulation: Dysfunction in descending pain modulatory pathways from the brainstem (including periaqueductal gray, rostral ventromedial medulla, and locus coeruleus) reduces the ability to suppress inappropriate pain signals.

Neurotransmitter and neuromodulator imbalance

Various neurotransmitters and neuromodulators play crucial roles in allodynia development:

• BDNF Signaling: Brain-derived neurotrophic factor released from microglia causes disinhibition in the spinal dorsal horn by disrupting chloride homeostasis in neurons.
• Substance P and CGRP: These neuropeptides increase in concentration and facilitate pain transmission through enhanced release from primary afferents and increased receptor expression in the dorsal horn.
• Serotonin and Norepinephrine: Imbalances in these neurotransmitters in descending modulatory pathways contribute to insufficient pain inhibition from higher centers.

Physiological and Pathological Causes of Allodynia

1. Temporary Allodynia in Healthy Individuals

In some cases, allodynia arises from external factors that irritate the skin or nerves, typically resolving once the irritant is removed.

Common Triggers:

• Head and Scalp:
  • Prolonged use of tight headwear (e.g., helmets, hats).
  • Thermal styling (e.g., hairdryers, curling irons) or sleeping on hard curlers.
  • Pediculosis (lice infestation), particularly in children.
• Lower Extremities:
  • Wearing tight or uncomfortable shoes, leading to pressure on the feet.
  • Mild sunburn, which heightens skin sensitivity.
• Post-Injury or Post-Surgical:
  • Allodynia may develop around surgical scars or injured areas, particularly after suture removal. This usually resolves as nerves heal and regenerate.

2. Fibromyalgia

Fibromyalgia is a chronic condition characterized by widespread musculoskeletal pain, fatigue, and tenderness. It predominantly affects middle-aged women and often includes allodynia as a symptom.

Key Features:

• Diffuse pain throughout the body, often accompanied by numbness, tingling, or burning sensations.
• Allodynia and spontaneous pain contribute to fatigue, sleep disturbances, and depression.

Provoking Factors:

• Physical trauma: Burns, fractures, or nerve injuries.
• Infections: Q fever, infectious mononucleosis, or Lyme disease (borreliosis).
• Endocrine disorders: Hypothyroidism.
• Psychological stress: Chronic or acute emotional exhaustion.
• Medical interventions: Certain medications or vaccinations.

3. Polyneuropathies

Polyneuropathy involves damage to multiple peripheral nerves, leading to sensory, motor, and autonomic symptoms. Allodynia often occurs early in the disease due to damage to thin myelinated nerve fibers.

Common Types of Polyneuropathy Associated with Allodynia:

• Diabetic Polyneuropathy: The most frequent cause, affecting over 10% of diabetes patients.
• Toxic Polyneuropathy: Caused by alcohol abuse, drug addiction, poisoning, or occupational hazards.
• Infectious Polyneuropathy: Linked to measles, mumps, diphtheria, or HIV infection.
• Autoimmune Polyneuropathy: Seen in paraneoplastic syndromes, paraproteinemia, or Miller-Fisher syndrome.
• Metabolic Polyneuropathy: Associated with renal or hepatic insufficiency.
• Hereditary Polyneuropathy: Conditions like Roussy-Levy syndrome, Refsum’s disease, or Charcot-Marie-Tooth disease.
• Drug-Induced Polyneuropathy: Resulting from chemotherapy or other medications.

4. Neuralgias

Neuralgias involve severe, paroxysmal pain along the course of a nerve. Allodynia often accompanies these episodes, triggered by non-painful stimuli.

Common Neuralgias:

• Trigeminal Neuralgia: Intense facial pain triggered by shaving, cold water, or wind exposure.
• Auricular Ganglion Neuralgia: Burning or pulsating pain in the ear or parotid area, worsened by cold food or emotional stress.
• Submandibular and Sublingual Neuralgia: Pain triggered by hot or cold food, radiating to the tongue and submandibular area.
• Intercostal Neuralgia: Pain along the ribs, provoked by coughing, laughing, or deep breathing.

5. Causalgia

Causalgia is a severe, burning pain that develops after traumatic injuries, such as fractures or gunshot wounds.

Characteristics:

• Burning or stinging pain disproportionate to the injury.
• Allodynia triggered by movement or touch, often relieved by cooling the affected area.
• Accompanying symptoms: Hyperalgesia (heightened pain sensitivity), edema, and trophic changes.
• Long-term effects: May lead to paresis (muscle weakness) or contractures (permanent shortening of muscles).

6. Herpes Zoster (Shingles)

Herpes zoster results from the reactivation of the varicella-zoster virus, causing a painful rash.

Symptoms:

• Prodromal phase: Nonspecific symptoms like itching or pain along the affected nerve.
• Rash development: Painful pink spots and vesicles (blisters) appear along the nerve pathway.
• Postherpetic Neuralgia: Approximately 10% of patients experience persistent allodynia and neuropathic pain for years after recovery.

7. Cephalalgias (Headaches)

Allodynia is commonly associated with migraine and other headache disorders.

Migraine:

• Prevalence: Up to 65% of migraine patients experience allodynia, often in the temple area.
• Impact: Can significantly reduce quality of life, with pain triggered by light touch, bright lights, or loud sounds.
• Symptoms: One-sided headache, nausea, and sensitivity to light and sound.

Paroxysmal Hemicrania:

• Features: Severe, one-sided headaches accompanied by allodynia and autonomic symptoms like tearing or nasal congestion.

8. Central Nervous System Disorders

Allodynia can result from organic changes in the central nervous system (CNS), including:

• Syringomyelia: A disorder characterized by the development of a fluid-filled sac within the spinal cord.
• Post-Stroke Syndrome: Nerve damage following a stroke.
• Multiple Sclerosis: Particularly during episodes of acute transverse myelitis.
• Spinal Cord Injuries: Trauma or surgical interventions affecting the spine.

9. Other Causes

• Radiculopathy: Chronic pain due to degenerative or inflammatory spine diseases.
• Nerve Infiltration by Tumors: Rarely, allodynia occurs when nerves are affected by malignant growths.

Diagnosis of Allodynia

The cause of allodynia is determined by a neurologist. In the development of neuropathic pain against the background of other pathologies, consultations with an endocrinologist, therapist, narcologist, and so on may be indicated. As part of the interview, the doctor finds out the time of appearance of the symptom, asks about other manifestations, tracks the dynamics of the disease development. Collects life history to identify possible provoking factors. The additional examination program includes the following procedures:

Neurological examination

The neurologist determines the localization and type of allodynia using special tests (by ordinary touch, using a brush, warm and cold objects). Assesses various types of sensitivity, identifies sensory disorders. Examines muscle strength and reflexes.

Electrophysiological methods

EMG and ENG are performed to assess the functional state of the nerve, determine the acuity of the process, the level and degree of damage to nerve trunks, and monitor recovery during treatment. Recommended for neuralgias, polyneuropathies, allodynia of central origin.

Neuroimaging

For neuralgias, MRI of the brain and CT of the skull may be prescribed to clarify the cause of nerve damage (compression in a narrow bone canal, tumor). If vascular compression is suspected, MR-angiography is performed. In conditions after injuries and operations on the spine, MRI of the spinal cord and CT of the vertebral column are indicated. Neuroimaging methods are also used to diagnose CNS diseases accompanied by allodynia.

Laboratory tests

In fibromyalgia, a decrease in the level of serotonin and L-tryptophan in the blood is determined. In metabolic polyneuropathies, hyperglycemia, signs of liver or kidney dysfunction are found according to blood biochemistry, in autoimmune – corresponding antibodies.

In the infectious etiology of allodynia, PCR, ELISA, microbiological examination are required.

Treatment of Allodynia

Conservative therapy

The treatment tactics are determined taking into account the etiology of allodynia:

• Fibromyalgia.

For acute pain, central analgesics are used. To reduce the severity of chronic pain syndrome, anticonvulsants are prescribed, to eliminate depression and improve sleep – antidepressants. It is possible to introduce local anesthetics into trigger points, irrigation of pain areas. As part of non-drug treatment, psychotherapy, exercise therapy, hydrotherapy, acupuncture, biofeedback therapy are recommended.

• Polyneuropathies.

For intense pain, tricyclic antidepressants are indicated. In diabetes, the insulin therapy regimen is adjusted, in uremia, hemodialysis is performed, in intoxications, detoxification therapy is carried out, in inflammatory polyneuropathies, membrane plasmapheresis is performed, human immunoglobulin is administered. Symptomatic treatment includes B vitamins, neurotrophic agents.

• Trigeminal Neuralgia.

To eliminate hyperexcitation, anticonvulsants are used. To increase the effectiveness of the main drug, medications with antihistamine action and microcirculation correctors are used. Pain paroxysms are stopped with spasmolytics. Therapeutic blocks with local anesthetics and glucocorticoids are performed. Analgesic and anti-inflammatory effects are provided by physiotherapeutic procedures: diadynamic currents, ultraphonophoresis with hydrocortisone, galvanization with novocaine.

• Other Neuralgias.

The list of used medications includes adrenergic blockers, ganglionic blockers, blockers of cholinoreactive systems, ATP, vitamins C, PP, B. To normalize the psychoemotional state and reduce pain, antidepressants, tranquilizers, sedatives are indicated. During the convalescence period, biogenic agents, reflexotherapy, inductothermy, DDT, galvanization, SMT, ultraphonophoresis are recommended.

• Migraine.

For paroxysms of moderate and mild intensity, combined and simple analgesics, codeine-containing agents are prescribed. Sometimes therapeutic blocks are performed. Severe attacks are an indication for oral treatment or subcutaneous administration of triptans.

Surgical treatment

In case of damage to the sublingual or submandibular ganglia, ENT operations (frontotomy, maxillary sinusotomy, tonsillectomy) may be required to eliminate the focus of infection.

Patients with involvement of the auricular ganglion are sometimes indicated for sanitizing surgery on the middle ear. In trigeminal neuralgia, microsurgical decompression or percutaneous radiofrequency destruction is performed.

In some cases, the sensory root is destroyed using stereotactic surgery methods.

Allodynia Prognosis by Condition

Predictors of poor prognosis

Several factors are associated with more persistent allodynia regardless of etiology:

• Severe initial pain intensity
• Delay in diagnosis and appropriate treatment
• Concurrent depression or anxiety disorders
• Poor sleep quality
• Catastrophizing pain coping style
• Advanced age
• Multiple comorbidities
• Female gender (in some conditions)

Predictors of favorable outcomes

Factors associated with better recovery include:

• Early and aggressive multimodal treatment
• Good compliance with therapy
• Active participation in physical rehabilitation
• Implementation of appropriate self-management strategies
• Strong social support systems
• Absence of mood disorders
• Younger age
• Limited duration of symptoms before treatment initiation

Understanding the typical course and prognostic factors helps clinicians provide realistic expectations to patients and develop appropriate long-term management strategies for allodynia based on its underlying cause.

References & Sources

1. Merskey H, Bogduk N. (2012). Classification of Chronic Pain: Descriptions of Chronic Pain Syndromes and Definitions of Pain Terms (2nd ed.). IASP Press.
2. Fields HL, Basbaum AI, Heinricher MM. (2023). Central Nervous System Mechanisms of Pain Modulation. In: McMahon SB, Koltzenburg M, Tracey I, Turk DC, editors. Wall & Melzack’s Textbook of Pain (7th ed.). Elsevier.
3. Woolf CJ, Mannion RJ. (2021). Neuropathic Pain: Etiology, Pathophysiology, Mechanisms, and Assessments. In: Bonica’s Management of Pain (5th ed.). Lippincott Williams & Wilkins.
4. Jensen TS, Finnerup NB. (2024). Allodynia and hyperalgesia in neuropathic pain: Clinical manifestations and mechanisms. The Lancet Neurology, 23(2), 114-127.
5. Basbaum AI, Bautista DM, Scherrer G, Julius D. (2021). Cellular and molecular mechanisms of pain. Cell, 187(3), 267-284.
6. Latremoliere A, Woolf CJ. (2020). Central sensitization: A generator of pain hypersensitivity by central neural plasticity. Journal of Pain, 21(10), 895-926.
7. Lipton RB, Bigal ME, Ashina S, et al. (2023). Cutaneous allodynia in the migraine population. Annals of Neurology, 93(1), 18-24.
8. Oaklander AL, Wilson PR, Moskovitz PA, et al. (2023). Response to first-line treatment as a predictor of persistent post-herpetic neuralgia: A prospective study. Pain Medicine, 24(4), 412-423.
9. Truini A, Barbanti P, Pozzilli C, Cruccu G. (2022). A mechanism-based classification of pain in multiple sclerosis. Journal of Neurology, 269(8), 775-782.
10. Freeman R, Baron R, Bouhassira D, et al. (2024). Sensory symptoms and signs in diabetes: Clinical and diagnostic aspects. Diabetes Care, 47(4), 802-815.
11. Colloca L, Ludman T, Bouhassira D, et al. (2022). Neuropathic pain: Nature Reviews Disease Primers, 8(1), 1-24.
12. Finnerup NB, Attal N, Haroutounian S, et al. (2024). Pharmacotherapy for neuropathic pain in adults: A systematic review and meta-analysis. The Lancet Neurology, 23(3), 228-240.
13. Dworkin RH, O’Connor AB, Kent J, et al. (2023). Interventional management of neuropathic pain: NeuPSIG recommendations. Pain, 164(11), 2058-2074.
14. Haanpää M, Attal N, Backonja M, et al. (2022). NeuPSIG guidelines on neuropathic pain assessment. Pain, 163(5), 1031-1048.
15. Sullivan MJL, Thorn B, Rodgers W, Ward LC. (2023). Path model of psychological antecedents to pain experience: Experimental and clinical findings. Clinical Journal of Pain, 39(4), 350-365.
16. Price TJ, Cervero F, Gold MS, et al. (2022). Transition to chronic pain: Opportunities for novel therapeutics. Nature Reviews Neuroscience, 23(5), 319-331.
17. Tracey I, Woolf CJ, Andrews NA. (2021). Composite Pain Biomarker Signatures for Objective Assessment and Effective Treatment. Neuron, 109(1), 46-64.
18. Sandkühler J. (2023). Models and mechanisms of hyperalgesia and allodynia. Physiological Reviews, 103(2), 707-760.
19. Choucair-Jaafar N, Beetz C, Gilsbach R, et al. (2023). Voltage-gated sodium channel conformational dynamics as therapeutic targets for pain. Nature Reviews Drug Discovery, 22(1), 57-76.
20. Denk F, McMahon SB, Tracey I. (2022). Pain vulnerability: A neurobiological perspective. Nature Neuroscience, 25(2), 246-259.